Maxine Weir

Maxine Weir is an experienced professional in the pharmaceutical and healthcare sectors, currently serving as Director of REMS Programs & Pharmacovigilance in Enterprise Quality Management at McKesson since August 2024. Prior to this role, Maxine held the position of Director of Regulatory Affairs & Compliance within the US Pharmaceutical Division at McKesson since April 2017, and served as Director of Compliance & Ethics at McKesson PSaS from April 2017 to August 2024, contributing to Master Data Governance and as an Enterprise REMS Authorized Representative. Maxine's extensive background includes roles at CVS Caremark Corporation as Sr. Advisor for Product Safety/Risk & Pharmacovigilance and Clinical Pharmacist Supervisor, as well as several positions at Giant Eagle, Thrift Drug, and Kay Drug Co. Maxine holds a Bachelor of Pharmacy degree from Duquesne University and a Bachelor of Science in Chemistry from the University of Pittsburgh, complemented by a certificate from the Dale Carnegie Sales Course.